J. Berg

发表

A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects

N. Youssef, B. Joelsson, Eric H Kim, 2014, BMC Gastroenterology.

Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease

D. Witcher, S. M. Truhlar, T. Marbury, 2019, British journal of clinical pharmacology.

Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus

N. Pannacciulli, O. Ben‐Yehuda, M. Allard, 2015, Clinical pharmacology in drug development.

Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function

Naeem D. Khan, Jonathan T. Lu, J. Berg, 2018, European Journal of Clinical Pharmacology.

Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function

S. Bai, L. Garrity-Ryan, J. Berg, 2017, Antimicrobial Agents and Chemotherapy.

Double-Blind , Randomized Study Evaluating the Glycemic and Anti-in fl ammatory Effects of Subcutaneous LY 2189102 , a Neutralizing IL-1 b Antibody , in PatientsWith Type 2 Diabetes

E. Abu-Raddad, A. Gaetano, W. Landschulz, 2013 .

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment

William Smith, K. Adkison, T. Marbury, 2015, Journal of clinical pharmacology.

Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics

T. Marbury, P. Covington, J. Berg, 2017, Journal of clinical pharmacology.

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.

L. Morrow, N. Vaccaro, P. Stein, 2014, Metabolism: clinical and experimental.

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor

Caroline A. Lee, T. Marbury, Zancong Shen, 2018, Clinical Drug Investigation.

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus

A. Hawi, C. Hines, J. Berg, 2015, BMC Nephrology.

Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment

R. Echols, H. Krenz, J. A. Arjona Ferreira, 2016, Journal of clinical pharmacology.

Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics

S. Mujais, D. Kowalski, S. Akhtar, 2017, European Journal of Clinical Pharmacology.

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

J. Chodakewitz, J. Wagner, T. Marbury, 2009, Antimicrobial Agents and Chemotherapy.

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study

S. Shenouda, A. Gray, J. Holcombe, 2011, Diabetes, obesity & metabolism.

Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes

Andrea De Gaetano, A. De Gaetano, E. Abu-Raddad, 2013, Diabetes Care.

Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End‐Stage Renal Disease on Maintenance Hemodialysis

P. Chaikin, J. Berg, S. Pai, 2019, Journal of clinical pharmacology.

Single and Multiple Oral Doses of LGD-4665, a Small Molecule Thrombopoietin Receptor Agonist, Increase Platelet Counts in Healthy Male Subjects

J. Berg, G. Loewen, Z. Jinkun, 2007 .

Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function

Naeem D. Khan, Jonathan T. Lu, J. Berg, 2018, European Journal of Clinical Pharmacology.

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.

L. Morrow, N. Vaccaro, P. Stein, 2014, Metabolism: clinical and experimental.